JAMA Internal Medicine
DECEMBER 8, 2024
This randomized clinical trial compares the effectiveness of an integrated pain team vs pharmacist collaborative management on pain and opioid dosage.
Drug Patent Watch
DECEMBER 8, 2024
The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
DECEMBER 8, 2024
This Clinical Insights discusses how the methicillin-resistant Staphylococcus aureus (MRSA) nares swab may be used alongside disease prevalence and clinical factors to determine when MRSA coverage is needed for common inpatient infections.
JAMA Internal Medicine
DECEMBER 8, 2024
This cohort study compares the rates of medical assistance in dying across diseases to understand the relative effects of disease and jurisdiction.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
JAMA Internal Medicine
DECEMBER 8, 2024
This cohort study assesses systematic depression screening and recommended initial treatment among those with elevated depressive symptoms and/or suicidal ideation and whether individuals historically at risk for undertreatment received equitable initial care.
Expert insights. Personalized for you.
76 
Let's personalize your content